⏳ Fetching live dividend data...
Home › Calculator › CEMI Dividend Calculator 2026
Chembio Diagnostics, Inc. · NASDAQ
Price: $0.46 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CEMI → $109773.43M in 10 years · $7,176,904,520.29/month
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the company is dedicated to advancing diagnostics for a wide array of other infectious diseases, such as malaria, dengue, chikungunya, Chagas disease, Ebola, leishmaniasis, Lassa fever, Marburg virus, leptospirosis, rickettsia, and Burkholderia infections. These diagnostic tools are sold under well-known brand names including STAT-PAK, SURE CHECK, STAT VIEW, and DPP. Chembio distributes its products directly and through various partners to a diverse global customer base. This clientele includes medical laboratories, hospitals, government and public health agencies, non-governmental organizations (NGOs), medical professionals, and retail outlets across the United States and worldwide. The company engages in strategic partnerships with prominent organizations such as the Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics. Additionally, Chembio collaborates with several key U.S. government entities, including the Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture (USDA). Founded in 1985, Chembio Diagnostics, Inc. has its headquarters located in Hauppauge, New York.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CEMI position with:
Real after-tax yield depends on where you live and how you hold CEMI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 439.56% | 436.76% | $43,956 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 373.63% | 370.83% | $37,363 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 351.65% | 348.85% | $35,165 / yr |
| 🇬🇧 UK ISA | 0% | 439.56% | 436.76% | $43,956 / yr |
| 🇬🇧 UK Taxable | 8.75% | 401.10% | 398.30% | $40,110 / yr |
| 🇨🇦 TFSA | 0% | 439.56% | 436.76% | $43,956 / yr |
| 🇨🇦 CA Taxable | 25% | 329.67% | 326.87% | $32,967 / yr |
| 🇦🇺 Super (pension) | 15% | 373.63% | 370.83% | $37,363 / yr |
| 🇦🇺 AU Taxable | 30% | 307.69% | 304.89% | $30,769 / yr |
| 🇩🇪 DE Taxable | 26.375% | 323.63% | 320.83% | $32,363 / yr |
| 🇫🇷 FR Taxable | 30% | 307.69% | 304.89% | $30,769 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CEMI pays quarterly — 4 times per year. Next ex-div: TBD.
How CEMI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CEMI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2023-03-11 | 29,333 | — | — | ||
| M-Exempt | 2023-03-15 | 7,885 | — | — | ||
| F-InKind | 2023-03-15 | 2,843 | $0.39 | $1.1K | ||
| F-InKind | 2023-03-11 | 10,575 | $0.44 | $4.7K | ||
| M-Exempt | 2023-03-11 | 29,333 | — | — | ||
| M-Exempt | 2022-10-28 | 10,594 | — | — | ||
| F-InKind | 2022-10-28 | 3,823 | $0.32 | $1.2K | ||
| M-Exempt | 2023-03-15 | 7,885 | — | — | ||
| D-Return | 2023-04-27 | 66,553 | — | — | ||
| D-Return | 2023-04-27 | 177,080 | $4.65 | $823.4K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CEMI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Chembio Diagnostics, Inc. (CEMI) is currently trading at $0.46, 94% below its 52-week high. The current dividend yield is 439.56% based on an annual payout of $2.00 per share.
Chembio Diagnostics, Inc. (CEMI) is a healthcare stock currently trading at $0.46 with a dividend yield of 439.56%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →